New award for topiramate tablets with exelan pharmaceuticals, INC. Period of performance is 10/31/2020 to 10/30/2021 with four one-year options.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79720D0064
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Topiramate Tablets Pre-Solicitation · 36E79720R0040 · Posted May 4, 2020
- 6505--Topiramate Tablets Effective 10/31/2020 - 10/30/2021 Award Notice · Posted Sep 24, 2020
- 6505--Topiramate Tablets Solicitation · Posted Jun 3, 2020
- Last date to order 100% complete
- IDV ceiling
- $32,360,809.00
- Award type
- Single award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is for the delivery of Topiramate tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The single-award, unrestricted contract was issued by the VA National Acquisition Center, with a total ceiling value of $32,360,809.00 and a period of performance from October 31, 2020 to October 30, 2025.
The prime contractor, Exelan Pharmaceuticals Inc., is a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida that specializes in manufacturing and distributing generic and branded pharmaceutical products to various federal healthcare agencies. The contract enables Exelan to provide an uninterrupted supply of Topiramate tablets in a range of dosages and package sizes to support the VA's and DoD's Pharmaceutical Prime Vendor Programs. The annual estimated requirements total over 200,000 bottles of Topiramate across multiple dose strengths, with the largest quantities for the 25mg and 100mg tablets.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Show all 15
Quick answers
Who was awarded contract 36E79720D0064?
36E79720D0064 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on October 31, 2020.
How much is contract 36E79720D0064 worth?
36E79720D0064's own ceiling is $32,360,809.
Who can order from contract 36E79720D0064?
36E79720D0064 is a single award indefinite delivery contract. All agencies can place orders on it.
Was contract 36E79720D0064 competed?
The extent of competition for 36E79720D0064 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV